Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global impact of COVID‐19 pandemic on the incidence of pediatric new‐onset type 1 diabetes and ketoacidosis: A systematic review and meta‐analysis
Masoud Rahmati, Maryam Keshvari, Shahrzad Mirnasuri, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5112-5127
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis
Ting Zhang, Qimin Mei, Zhaocai Zhang, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 117
Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic
D.M. D'Souza, Jessica Empringham, Petros Pechlivanoglou, et al.
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2321281-e2321281
Open Access | Times Cited: 68
SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study
Mikael Knip, Anna Parviainen, Maaret Turtinen, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 4, pp. 251-260
Open Access | Times Cited: 31
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 28
Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the COVID-19 pandemic 2020 and 2021: Current data from the DPV Registry
Christina Baechle, Alexander J. Eckert, Clemens Kamrath, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110559-110559
Closed Access | Times Cited: 24
Deep learning in public health: Comparative predictive models for COVID-19 case forecasting
Muhammad Usman Tariq, Shuhaida Ismail
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0294289-e0294289
Open Access | Times Cited: 10
The impact of the COVID-19 pandemic and associated disruptions in health-care provision on clinical outcomes in people with diabetes: a systematic review
Jamie Hartmann‐Boyce, Patrick Highton, Karen Rees, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 2, pp. 132-148
Closed Access | Times Cited: 9
Type 1 diabetes: A new vision of the disease based on endotypes
Craig Sinclair Weston, Bernhard O. Boehm, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 8
Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes: Ongoing Challenges in Care
Simone Foti Randazzese, Mariarosaria La Rocca, Bruno Bombaci, et al.
Children (2025) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 1
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 32
Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study
Raffaele Izzo, Daniela Pacella, Valentina Trimarco, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102345-102345
Open Access | Times Cited: 19
Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 1, pp. 34-39
Open Access | Times Cited: 8
Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review
Chengchen Duan, Liu Liu, Tianyi Wang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
Liuliu Yang, Yuling Han, Tuo Zhang, et al.
Cell stem cell (2024) Vol. 31, Iss. 11, pp. 1612-1629.e8
Open Access | Times Cited: 7
Trends in the Incidence of Type 1 Diabetes in European Children and Adolescents from 1994 to 2022: A Systematic Review and Meta-Analysis
Marta Carolina Ruiz-Grao, Ana Díez‐Fernández, Arthur Eumann Mesas, et al.
Pediatric Diabetes (2024) Vol. 2024, pp. 1-13
Open Access | Times Cited: 6
The Influence of SARS-CoV-2 Pandemic on the Diagnosis of Celiac Disease and Clinical Practice in Pediatric Gastroenterology
Marco Crocco, Angela Calvi, Francesca Canzoneri, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 559-559
Open Access | Times Cited: 16
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16
Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis
Ignacio Hormazábal‐Aguayo, Yasmín Ezzatvar, Nidia Huerta‐Uribe, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 3
Open Access | Times Cited: 16
Is COVID-19 to Blame? Trends of Incidence and Sex Ratio in Youth-Onset Type 2 Diabetes in Germany
Christian Denzer, Joachim Rosenbauer, Daniela Klose, et al.
Diabetes Care (2023) Vol. 46, Iss. 7, pp. 1379-1387
Open Access | Times Cited: 15
Covid 19 and diabetes in children: advances and strategies
Zhaoyuan Wu, Jinling Wang, Rahim Ullah, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 588-599
Closed Access | Times Cited: 5
Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus
Emmanuel Kokori, Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Non-human primate model of long-COVID identifies immune associates of hyperglycemia
Clovis S. Palmer, Chrysostomos Perdios, Mohamed Abdel‐Mohsen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics
Silvia Fotea, Cristina Mihaela Ghiciuc, Gabriela Ștefănescu, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2436-2436
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top